Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
An important aspect of modern medicine is its orientation to achieve more personalized pharmacological treatments. In this context, transporters involved in drug disposition have gained well-justified attention. Owing to its broad spectrum of substrate specificity, including endogenous compounds and...
Main Authors: | Elisa Lozano, Oscar Briz, Rocio I. R. Macias, Maria A. Serrano, Jose J. G. Marin, Elisa Herraez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4426/8/2/14 |
Similar Items
-
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
by: Karin Brecht, et al.
Published: (2020-08-01) -
SLC22A1 And ATM Genes Polymorphisms Are Associated With The Risk Of Type 2 Diabetes Mellitus In Western Saudi Arabia: A Case-Control Study
by: Altall RM, et al.
Published: (2019-11-01) -
Role of OCTN1 (SLC22A4) in the Disposition of Nucleoside Analogs in AML
by: Anderson, Jason T., PharmD
Published: (2019) -
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01) -
GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial
by: Dan Dan Tian, et al.
Published: (2019-12-01)